184 related articles for article (PubMed ID: 6221540)
1. Novel 7-oxabicyclo[2.2.1]heptane prostacyclin agonists.
Haslanger MF; Sprague PW; Snitman D; Vu T; Harris DN; Greenberg R; Powell J
Adv Prostaglandin Thromboxane Leukot Res; 1983; 11():293-7. PubMed ID: 6221540
[No Abstract] [Full Text] [Related]
2. Stereocontrolled synthesis of 7-oxabicyclo (2.2.1) heptane prostaglandin analogs as thromboxane A2 antagonists.
Sprague PW; Heikes JE; Harris DN; Greenberg R
Adv Prostaglandin Thromboxane Res; 1980; 6():493-6. PubMed ID: 7189952
[No Abstract] [Full Text] [Related]
3. Aza-substituted omega-side-chain modifications of 7-oxabicyclo[2.2.1]heptane thromboxane A2 receptor antagonists: structure-activity relationships.
Nakane M; Reid JA; Haslanger MF; Garber DP; Harris DN; Ogletree ML; Greenberg R
Adv Prostaglandin Thromboxane Leukot Res; 1985; 15():291-3. PubMed ID: 3004140
[No Abstract] [Full Text] [Related]
4. Inhibition of human platelet aggregation by stable analogs of prostacyclin.
Togna G; GAndolfi C; Andreoni A; Fumagalli A; Passarotti C; Faustini F; Patrono C
Pharmacol Res Commun; 1977 Nov; 9(10):909-16. PubMed ID: 343117
[No Abstract] [Full Text] [Related]
5. Platelet sensitivity to prostacyclin in pregnancy and uterine cancer.
Briel RC; Lippert TH
Eur J Obstet Gynecol Reprod Biol; 1981 Jun; 12(1):19-23. PubMed ID: 7018952
[TBL] [Abstract][Full Text] [Related]
6. Effects of PGI2 on platelet aggregation induced by various stimulants.
Ohtsu A; Hoshina K; Kurozumi S; Hashimoto Y; Noguchi T; Nicolaou KC
Nihon Ketsueki Gakkai Zasshi; 1979 Aug; 42(4):659-66. PubMed ID: 388963
[No Abstract] [Full Text] [Related]
7. Synthesis and pharmacological evaluation of 5,6-exo-epoxy-7-oxabicyclo[2.2.1]heptane derivatives.
Das J; Vu T; Harris DN; Ogletree ML
J Med Chem; 1988 May; 31(5):930-5. PubMed ID: 2966247
[TBL] [Abstract][Full Text] [Related]
8. Effect of prostacyclin on platelet-activating factor induced rabbit and platelet aggregation.
Bussolino F; Camussi G
Prostaglandins; 1980 Nov; 20(5):781-91. PubMed ID: 6258196
[TBL] [Abstract][Full Text] [Related]
9. Prostacyclin increases cyclic AMP levels and adenylate cyclase activity in platelets.
Best LC; Martin TJ; Russell RG; Preston FE
Nature; 1977 Jun; 267(5614):850-2. PubMed ID: 197414
[No Abstract] [Full Text] [Related]
10. Comparison of the activities of prostacyclin and its stable analogs on the platelet aggregation and cardiovascular systems.
Kawasaki A; Ishii K; Wakitani K; Tsuboshima M
Adv Prostaglandin Thromboxane Res; 1980; 6():331-6. PubMed ID: 6992531
[No Abstract] [Full Text] [Related]
11. [Synthesis and antiaggregation activity of prostacyclin analogs. 1. Bicyclo [3.2.0] heptane analogs].
Lopp MI; Miuraus AI; Parve OV; Vialimiaé TK; Lopp AKh
Bioorg Khim; 1988 Feb; 14(2):222-31. PubMed ID: 3289544
[TBL] [Abstract][Full Text] [Related]
12. Synthesis of prostanoids with bicyclo[2.2.1]heptane, bicyclo[3.1.1]heptane, and bicyclo[2.2.2]octane ring systems. Activities of 15-hydroxy epimers on human platelets.
Wilson NH; Peesapati V; Jones RL; Hamilton K
J Med Chem; 1982 May; 25(5):495-500. PubMed ID: 7086834
[TBL] [Abstract][Full Text] [Related]
13. Stimulated platelet aggregation, thromboxane B2 formation and platelet sensitivity to prostacyclin - a critical evaluation.
Siess W; Roth P; Weber PC
Thromb Haemost; 1981 Jun; 45(3):204-7. PubMed ID: 7025338
[TBL] [Abstract][Full Text] [Related]
14. Prostaglandin endoperoxides and thromboxanes: role in platelets and in vascular and respiratory smooth muscle.
Samuelsson B
Acta Biol Med Ger; 1976; 35(8-9):1055-63. PubMed ID: 1007751
[TBL] [Abstract][Full Text] [Related]
15. Generation of prostacyclin by lungs in vivo and its release into the arterial circulation.
Gryglewski RJ; Korbut R; Ocetkiewicz A
Nature; 1978 Jun; 273(5665):765-7. PubMed ID: 351417
[No Abstract] [Full Text] [Related]
16. Evaluation of prostaglandin and prostacyclin antagonism at platelet receptors by aggregometry.
Eggerman TL; Harker LA; Andersen NH; Wilson CH
Adv Prostaglandin Thromboxane Res; 1980; 6():389-93. PubMed ID: 6247888
[No Abstract] [Full Text] [Related]
17. [Antiaggregation activity of various synthetic prostaglandins].
Kudriashov SA; Geling NG; Mel'nikova VI; Pivnitskiĭ KK
Biull Eksp Biol Med; 1982 Nov; 94(11):7-9. PubMed ID: 6758877
[No Abstract] [Full Text] [Related]
18. Carbacyclin--a potent stable prostacyclin analogue for the inhibition of platelet aggregation.
Whittle BJ; Moncada S; Whiting F; Vane JR
Prostaglandins; 1980 Apr; 19(4):605-27. PubMed ID: 6992234
[TBL] [Abstract][Full Text] [Related]
19. Platelet alterations in shear flow: dose response of prostacyclin on human platelets.
Hung TC; Butter DB; Graham MF; Lewis JH; Zhao JQ; Haubold AD
Trans Am Soc Artif Intern Organs; 1983; 29():436-41. PubMed ID: 6424310
[No Abstract] [Full Text] [Related]
20. Influence on platelet activity and red cell fluidity of epoprostenol and two stable prostacyclin analogues in vitro.
Maurin N
Arzneimittelforschung; 1986 Aug; 36(8):1180-3. PubMed ID: 3096342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
